Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AbbVie
Eli Lilly and Company
Nammi Therapeutics Inc
Eli Lilly and Company
Institut Paoli-Calmettes
Tomsk National Research Medical Center of the Russian Academy of Sciences
ViroMissile, Inc.
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
General Oncology, Inc.
City of Hope Medical Center
SN BioScience
Eli Lilly and Company
University of Washington
Abramson Cancer Center at Penn Medicine
Nuvation Bio Inc.
Actym Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Exelixis
Memgen, Inc.
GONGCHU Biotechnology Co., Ltd
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Novita Pharmaceuticals, Inc.
NextPoint Therapeutics, Inc.
Novartis
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Orion Biotechnology Polska Sp. z o.o.
Exelixis
National Cancer Institute (NCI)
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Eli Lilly and Company
Astellas Pharma Inc
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
Danatlas Pharmaceuticals Co., Ltd
Pfizer
NantBioScience, Inc.
Xencor, Inc.
Pfizer